Title: Fetuin-A: A Relevant Novel Serum Biomarker for Non-Invasive Diagnosis of Metabolic
Dysfunction-Associated Steatotic Liver Disease (MASLD): A Retrospective Case-control Study
Version: 2 Date: 14 Jun 2024
Reviewer:  Anwar Abouelnasr
Reviewer's report:
Dear Authors, please address the following points below :
-The switch from NAFLD to MASLD nomenclature should be noted in the introduction section.
Later on, the description of MASLD should take the place of the definitions of NAFLD and
NASH.
-You should provide a brief essay explaining the composition, synthesis, and function of fetuin
A.
- 'Cases' in the materials and techniques section should be defined using radiological techniques.
- All patients should also have their FIB-4 score, which is widely used, calculated and associated
with their fetuin A levels.
-The outcomes of the non-invasive scores on different MASLD patients might be contributed
to the discussion area.
-In the discussion section, it would be beneficial to highlight the findings related to fetuin and
provide readers with information on related research including BMI, transaminases, and fetuin.
-The benefits of the research ought to be emphasised.
Title: Fetuin-A: A Relevant Novel Serum Biomarker for Non-Invasive Diagnosis of Metabolic
Dysfunction-Associated Steatotic Liver Disease (MASLD): A Retrospective Case-control Study
Version: 2 Date: 14 Jun 2024
Reviewer:  Anwar Abouelnasr
Reviewer's report:
Dear Authors, please address the following points below :
-The switch from NAFLD to MASLD nomenclature should be noted in the introduction section.
Later on, the description of MASLD should take the place of the definitions of NAFLD and
NASH.
-You should provide a brief essay explaining the composition, synthesis, and function of fetuin
A.
- 'Cases' in the materials and techniques section should be defined using radiological techniques.
- All patients should also have their FIB-4 score, which is widely used, calculated and associated
with their fetuin A levels.
-The outcomes of the non-invasive scores on different MASLD patients might be contributed
to the discussion area.
-In the discussion section, it would be beneficial to highlight the findings related to fetuin and
provide readers with information on related research including BMI, transaminases, and fetuin.
-The benefits of the research ought to be emphasised.
Please review this paper.
user
Title: Fetuin-A: A Relevant Novel Serum Biomarker for Non-Invasive Diagnosis of Metabolic
Dysfunction-Associated Steatotic Liver Disease (MASLD): A Retrospective Case-control Study
Version: 2 Date: 14 Jun 2024
Reviewer:  Anwar Abouelnasr
Reviewer's report:
Dear Authors, please address the following points below :
-The switch from NAFLD to MASLD nomenclature should be noted in the introduction section.
Later on, the description of MASLD should take the place of the definitions of NAFLD and
NASH.
-You should provide a brief essay explaining the composition, synthesis, and function of fetuin
A.
- 'Cases' in the materials and techniques section should be defined using radiological techniques.
- All patients should also have their FIB-4 score, which is widely used, calculated and associated
with their fetuin A levels.
-The outcomes of the non-invasive scores on different MASLD patients might be contributed
to the discussion area.
-In the discussion section, it would be beneficial to highlight the findings related to fetuin and
provide readers with information on related research including BMI, transaminases, and fetuin.
-The benefits of the research ought to be emphasised.
assistant